0001562180-24-001391.txt : 20240216 0001562180-24-001391.hdr.sgml : 20240216 20240216163858 ACCESSION NUMBER: 0001562180-24-001391 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20240215 FILED AS OF DATE: 20240216 DATE AS OF CHANGE: 20240216 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Beliveau-Dunn Jeanne CENTRAL INDEX KEY: 0001714894 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35229 FILM NUMBER: 24649018 MAIL ADDRESS: STREET 1: C/O XYLEM INC. STREET 2: 1 INTERNATIONAL DRIVE CITY: RYE BROOK STATE: NY ZIP: 10573 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Xylem Inc. CENTRAL INDEX KEY: 0001524472 STANDARD INDUSTRIAL CLASSIFICATION: PUMPS & PUMPING EQUIPMENT [3561] ORGANIZATION NAME: 06 Technology IRS NUMBER: 452080495 STATE OF INCORPORATION: IN FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 301 WATER STREET SE CITY: WASHINGTON STATE: DC ZIP: 20003 BUSINESS PHONE: 202-869-9150 MAIL ADDRESS: STREET 1: 301 WATER STREET SE CITY: WASHINGTON STATE: DC ZIP: 20003 FORMER COMPANY: FORMER CONFORMED NAME: ITT WCO, Inc. DATE OF NAME CHANGE: 20110628 4 1 primarydocument.xml PRIMARY DOCUMENT X0508 4 2024-02-15 false 0001524472 Xylem Inc. XYL 0001714894 Beliveau-Dunn Jeanne C/O XYLEM INC. 301 WATER STREET SE WASHINGTON DC 20003 true false false false false Common Stock 2024-02-15 4 S false 1835.00 124.5075 D 7298.00 D This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). 1,835 Shares were executed at a range of prices from $124.4915 to $125.4914. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price. /s/ Seaneen Cline, by power of attorney for Jeanne Beliveau-Dunn 2024-02-16 EX-24 2 beliveaudunn_poa.txt J BELIVEAU-DUNN POA POWER OF ATTORNEY The undersigned, Jeanne Beliveau-Dunn, does hereby nominate constitute and appoint each of Kelly O'Shea, Juliene Patton, Callie Plant, Seaneen Cline and Dorothy Capers as his/her/their true and lawful attorneys and agents to do any and all acts and things and execute and file any and all instruments which said attorneys and agents may deem necessary or advisable to enable the undersigned (in his/her/their individual capacity or in any other capacity) to comply with the Securities Exchange Act of 1934 (the "34 Act") and the Securities Act of 1933 (the "33 Act") and any requirements of the Securities and Exchange Commission (the "SEC") in respect thereof, in connection with the preparation, execution and/or filing of (i) any report or statement of beneficial ownership or changes in beneficial ownership of securities of Xylem Inc., an Indiana corporation (the "Company"), that the undersigned (in his/her/their individual capacity or in any other capacity) may be required to file pursuant to Section 16(a) of the 34 Act, including any report or statement on Form 3, Form 4 or Form 5, or to any amendment thereto, (ii) any report or notice required under Rule 144 of the 33 Act, including Form 144, or any amendment thereto relating to the undersigned's role with, or beneficial ownership of, the Company's securities, and (iii) any and all other documents or instruments that may be necessary or desirable in connection with or in furtherance of any of the foregoing, including Form ID, or any amendments thereto, and any other documents necessary or appropriate to obtain codes and passwords enabling the undersigned to make electronic filings with the SEC of reports required pursuant to Section 16(a) of the 34 Act or any rule or regulation of the SEC,such power and authority to extend to any form or forms adopted by the SEC in lieu of or in addition to any of the foregoing and to include full power and authority to sign the undersigned's name in his/her/their individual capacity or otherwise, hereby ratifying and confirming all that said attorneys and agents or any of them, shall do or cause to be done by virtue thereof. This authorization shall supersede all prior authorizations to act for the undersigned with respect to securities of the Company in such matters, which prior authorizations are hereby revoked, and shall remain in effect until the undersigned is no longer required to file Form 3, 4 or 5 with respect to the undersigned's holdings of and transactions in securities issued by the Company unless earlier revoked, by the undersigned in a signed writing delivered to the foregoing attorneys in fact. IN WITNESS WHEREOF, I have hereunto set my hand this 7th day of November 2023. _____________________________ /s/ Jeanne Beliveau-Dunn